Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Familial platelet disorder with predisposition to acute myelogenous leukaemia (FPD/AML, MIM 601399) is an autosomal dominant disorder characterized by qualitative and quantitative platelet defects, and propensity to develop acute myelogenous leukaemia (AML). Informative recombination events in 6 FPD/AML pedigrees with evidence of linkage to markers on chromosome 21q identified an 880-kb interval containing the disease gene. Mutational analysis of regional candidate genes showed nonsense mutations or intragenic deletion of one allele of the haematopoietic transcription factor CBFA2 (formerly AML1) that co-segregated with the disease in four FPD/AML pedigrees. We identified heterozygous CBFA2 missense mutations that co-segregated with the disease in the remaining two FPD/AML pedigrees at phylogenetically conserved amino acids R166 and R201, respectively. Analysis of bone marrow or peripheral blood cells from affected FPD/AML individuals showed a decrement in megakaryocyte colony formation, demonstrating that CBFA2 dosage affects megakaryopoiesis. Our findings support a model for FPD/AML in which haploinsufficiency of CBFA2 causes an autosomal dominant congenital platelet defect and predisposes to the acquisition of additional mutations that cause leukaemia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The transcription factor RUNX-1 plays a key role in megakaryocyte differentiation and is mutated in cases of myelodysplastic syndrome and leukemia.”
From Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development. (2009) · cites this paper as [48]
In the citing paper
“Germ line mutations in RUNX-1 cause familial platelet disorder with the propensity to develop acute myelogenous leukemia (FPD/AML), a rare autosomal dominant disorder characterized by quantitative and qualitative platelet defects and a high incidence of developing myelodysplastic syndrome (MDS) and leukemia”
From Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development. (2009) · cites this paper as [48]
Citations
Cites
Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., & Downing, J. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80986-1 · Cited by 1,856
de Thé, H., Chomienne, C., Lanotte, M., Degos, L., & Dejean, A. (1990) · Nature · doi:10.1038/347558a0 · Cited by 1,355 · cited 1×
“Fusion of PDGF Receptor β to a novel ETS-like gene, TEL, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation.”
BackgroundWang, Q., Stacy, T., Binder, M., Marin-Padilla, M., Sharpe, A. H., & Speck, N. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3444 · Cited by 1,178
Self-citationGolub, T. R., Barker, G. F., Lovett, M., & Gilliland, D. G. (1994) · Cell · doi:10.1016/0092-8674(94)90322-0 · Cited by 1,155
Self-citationOncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis.
Weinberg, R. A. (1989) · PubMed · Cited by 949
The murine gene p27Kip1 is haplo-insufficient for tumour suppression
Fero, M. L., Randel, E., Gurley, K. E., Roberts, J. M., & Kemp, C. J. (1998) · Nature · doi:10.1038/24179 · Cited by 784
Fusion Between Transcription Factor CBFβ/PEBP2β and a Myosin Heavy Chain in Acute Myeloid Leukemia
Liu, P., Tarlé, S. A., Hajra, A., Claxton, D. F., Marlton, P., Freedman, M., Siciliano, M. J., & Collins, F. S. (1993) · Science · doi:10.1126/science.8351518 · Cited by 732 · cited 1×
“; the CBFB / MYH11 fusion associated with inv(16) myelomonocytic leukaemia with eosinophili”
BackgroundFusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.
Golub, T. R., Barker, G. F., Bohlander, S. K., Hiebert, S. W., Ward, D. C., Bray-Ward, P., Morgan, E., Raimondi, S. C., Rowley, J. D., & Gilliland, D. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4917 · Cited by 704
Self-citationShivdasani, R. A., Rosenblatt, M. F., Zucker-Franklin, D., Jackson, C. W., Hunt, P., Saris, C. J. M., & Orkin, S. H. (1995) · Cell · doi:10.1016/0092-8674(95)90531-6 · Cited by 693 · cited 1×
“It is notable that mice hemizygous for genes required for megakaryopoiesis, such as Gata1 , Nfe2 and fog , have apparent platelet defect”
BackgroundShivdasani, R. A., Fujiwara, Y., McDevitt, M. A., & Orkin, S. H. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3965 · Cited by 674 · cited 1×
“It is notable that mice hemizygous for genes required for megakaryopoiesis, such as Gata1 , Nfe2 and fog , have apparent platelet defect”
Background
Cited by
Items 401–500 of 1,000
Point Mutations of the RUNX1/AML1 Gene in Sporadic and Familial Myeloid Leukemias
Osato, M., Yanagida, M., Shigesada, K., & Itoa, Y. (2001) · International Journal of Hematology · doi:10.1007/bf02982056 · Cited by 53
Inherited Platelet Function Disorders
Rao, A. K. (2013) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2013.02.005 · Cited by 55
Johnson, B., Fletcher, S. J., & Morgan, N. V. (2016) · Platelets · doi:10.3109/09537104.2016.1148806 · Cited by 53
“Similar to FLI-1, ETV6 and AML-1, HOXA11 is a DNAbinding protein, which is expressed, like many other homeodomain box proteins, in human cord blood and hematopoietic precursor cells [15].”
Genetics of inherited thrombocytopenias
Warren, J. T., & Paola, J. D. (2022) · Blood · doi:10.1182/blood.2020009300 · Cited by 50
A critical role of RUNX1 in governing megakaryocyte-primed hematopoietic stem cell differentiation
Wang, C., Tu, Z., Cai, X., Wang, W., Davis, A. K., Nattamai, K., Paranjpe, A., Dexheimer, P. J., Wu, J., Huang, F. L., et al. (2023) · Blood Advances · doi:10.1182/bloodadvances.2022008591 · Cited by 51
Cornell, R. F., & Palmer, J. M. (2012) · Disease-a-Month · doi:10.1016/j.disamonth.2012.01.011 · Cited by 58
T cell acute lymphoblastic leukemia arising from familial platelet disorder
Nishimoto, N., Imai, Y., Ueda, K., Nakagawa, M. M., Shinohara, A., Ichikawa, M., Nannya, Y., & Kurokawa, M. (2010) · International Journal of Hematology · doi:10.1007/s12185-010-0612-y · Cited by 48
“The responsible gene for this disease was marked on 21q22 by linkage analysis [2] and was subsequently identified as the RUNX1 gene which is mapped on 21q22 [3].”
BackgroundGenomics of AML: Clinical Applications of Next-Generation Sequencing
Welch, J. S., & Link, D. C. (2011) · Hematology · doi:10.1182/asheducation-2011.1.30 · Cited by 58
Pathak, A. B., Seipel, K., Pemov, A., Dewan, R., Brown, C. D., Ravichandran, S., Luke, B. T., Malasky, M., Suman, S., Yeager, M., et al. (2015) · Haematologica · doi:10.3324/haematol.2015.130799 · Cited by 49
RUNX transcription factors at the interface of stem cells and cancer
Deltcheva, E. M., & Nimmo, R. A. (2017) · Biochemical Journal · doi:10.1042/bcj20160632 · Cited by 53
Castro, P. D., Hong, L., Liang, J. C., & Nagarajan, L. (2002) · Genomics · doi:10.1006/geno.2002.6805 · Cited by 48
C-terminal mutation of RUNX1 attenuates the DNA-damage repair response in hematopoietic stem cells
Satoh, Y., Matsumura, I., Tanaka, H., Harada, H., Harada, Y., Matsui, K., Shibata, M., Mizuki, M., & Kanakura, Y. (2011) · Leukemia · doi:10.1038/leu.2011.202 · Cited by 51
Recent advances in understanding the molecular pathogenesis of myelodysplastic syndromes
Kulasekararaj, A. G., Mohamedali, A. M., & Mufti, G. J. (2013) · British Journal of Haematology · doi:10.1111/bjh.12435 · Cited by 55
Zhang, L., Padron, E., & Lancet, J. E. (2014) · Leukemia Research · doi:10.1016/j.leukres.2014.10.006 · Cited by 57
Stengel, A., Kern, W., Meggendorfer, M., Nadarajah, N., Perglerová, K., Haferlach, T., & Haferlach, C. (2017) · Leukemia · doi:10.1038/leu.2017.239 · Cited by 49
The genetics of human hematopoiesis and its disruption in disease
Bao, E. L., Cheng, A. N., & Sankaran, V. G. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201910316 · Cited by 42
“Another example in which RVAS has enhanced our understanding of a known hematopoietic regulator is exemplified by human variation impacting RUNX1.”
BackgroundInfluentialGeddis, A. E. (2006) · Seminars in Hematology · doi:10.1053/j.seminhematol.2006.04.003 · Cited by 47
Nineteen Additional Unpredicted Transcripts from Human Chromosome 21
Reymond, A., Camargo, A. A., Deutsch, S., Stevenson, B. J., Parmigiani, R. B., Ucla, C., Bettoni, F., Rossier, C., Lyle, R., Guipponi, M., et al. (2002) · Genomics · doi:10.1006/geno.2002.6781 · Cited by 47
Comprehensive genotypic analysis of leukemia: clinical and therapeutic implications
Kelly, L., Clark, J., & Gilliland, D. G. (2002) · Current Opinion in Oncology · doi:10.1097/00001622-200201000-00003 · Cited by 47
Self-citationSomatic genetic alterations predict hematological progression in GATA2 deficiency
Largeaud, L., Collin, M., Monselet, N., Vergez, F., Fregona, V., Larcher, L., Hirsch, P., Duployez, N., Bidet, A., Luquet, I., et al. (2023) · Haematologica · doi:10.3324/haematol.2022.282250 · Cited by 46
“Somatic mutations in STAG2, ASXL1 and SETBP1 genes along with cytogenetic abnormalities (monosomy 7, trisomy 8, der(1;7)) occurred frequently in patients with GATA2 germline mutations.”
BackgroundHoman, C. C., Drazer, M. W., Yu, K., Lawrence, D., Feng, J., Arriola‐Martinez, L., Pozsgai, M. J., McNeely, K. E., Ha, T., Venugopal, P., et al. (2023) · Blood Advances · doi:10.1182/bloodadvances.2023010045 · Cited by 47
Yu, K., Deuitch, N. T., Merguerian, M., Cunningham, L., Davis, J., Bresciani, E., Diemer, J. L., Andrews, E. T., Young, A., Donovan, F. X., et al. (2024) · Blood Advances · doi:10.1182/bloodadvances.2023011165 · Cited by 47
RUNX1: A MicroRNA Hub in Normal and Malignant Hematopoiesis
Rossetti, S., & Sacchi, N. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14011566 · Cited by 51
“The identification of inherited mono-allelic RUNX1 intragenic deletions in familial platelet disorder (FPD), which is associated with a higher risk to develop AML, points to RUNX1 haploinsufficiency, and not only RUNX1 translocations, as a leukemia pre-disposing factor [104].”
BackgroundProtein kinase C-theta in platelet activation
Cohen-Schwartz, S., Braiman, A., Shubinsky, G., & Isakov, N. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.09.014 · Cited by 51
“penia and platelet dysfunction [96], was found to be associated with reduced expression of PKCh in platelets [74].”
BackgroundHuman NOTCH4 is a key target of RUNX1 in megakaryocytic differentiation
Li, Y., Jin, C., Bai, H., Gao, Y., Sun, S. F., Chen, L., Qin, L., Liu, P., Cheng, L., & Wang, Q. (2017) · Blood · doi:10.1182/blood-2017-04-780379 · Cited by 46
Germline mutations in the transcription factor IKZF5 cause thrombocytopenia
Lentaigne, C., Greene, D., Sivapalaratnam, S., Favier, R., Seyres, D., Thys, C., Grassi, L., Mangles, S., Sibson, K. R., Stubbs, M. J., et al. (2019) · Blood · doi:10.1182/blood.2019000782 · Cited by 48
Germline RUNX1 variation and predisposition to childhood acute lymphoblastic leukemia
Li, Y., Yang, W., Devidas, M., Winter, S. S., Kesserwan, C. A., Yang, W., Dunsmore, K. P., Smith, C. J., Qian, M., Zhao, X., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci147898 · Cited by 49
Self-citationTawana, K., Brown, A. L., & Churpek, J. E. (2021) · British Journal of Haematology · doi:10.1111/bjh.17855 · Cited by 46
Yoshida, T., Kanegane, H., Osato, M., Yanagida, M., Miyawaki, T., Ito, Y., & Shigesada, K. (2003) · Blood Cells Molecules and Diseases · doi:10.1016/s1079-9796(03)00020-2 · Cited by 49
Cuenco, G. M., & Ren, R. (2004) · Oncogene · doi:10.1038/sj.onc.1207143 · Cited by 55
“The haploinsufficiency of AML1/RUNX1 found in familial thrombocytopenia with a propensity to develop AML suggests that CBFs also have tumor suppression functions (Song et al., 1999).”
BackgroundJab1/CSN5 induces the cytoplasmic localization and degradation of RUNX3
Kim, J., Choi, J.-K., Cinghu, S., Jang, J., Lee, Y., Li, Y., Goh, Y., Chi, X., Lee, K., Wee, H., et al. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22157 · Cited by 45
“Decreased levels of RUNX1 and RUNX2 activity result in leukemia [Osato et al., 1999; Song et al., 1999] and cleidocranial cysplasia [Quack et al.”
BackgroundInfluentialYokota, A., Huo, L., Lan, F., Wu, J., & Huang, G. (2020) · PubMed Central · doi:10.14348/molcells.2019.0252 · Cited by 67
“FPD/AML is caused by germline mutations of RUNX1, which is located at 21q22 and plays pivotal roles in the regulation of hematopoietic differentiation (Song et al., 1999).”
BackgroundRipperger, T., Steinemann, D., Göhring, G., Finke, J., Niemeyer, C. M., Strahm, B., & Schlegelberger, B. (2009) · Leukemia · doi:10.1038/leu.2009.87 · Cited by 45
Kratz, C. P., Emerling, B. M., Donovan, S., Laig-Webster, M., Taylor, B. R., Thompson, P., Jensen, S., Banerjee, A., Bonifas, J. M., Makałowski, W., et al. (2001) · Genomics · doi:10.1006/geno.2001.6636 · Cited by 45
A Chromatin Immunoprecipitation Screen Reveals Protein Kinase Cβ as a Direct RUNX1 Target Gene
Hug, B. A., Ahmed, N., Robbins, J. A., & Lazar, M. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309524200 · Cited by 47
The Gene for May-Hegglin Anomaly Localizes to a <1-Mb Region on Chromosome 22q12.3-13.1
Martignetti, J. A., Heath, K. E., Harris, J. M., Bizzaro, N., Savoia, A., Balduini, C. L., & Desnick, R. J. (2000) · The American Journal of Human Genetics · doi:10.1086/302873 · Cited by 45
“On the basis of this localization, mutational analysis of candidate genes showed that haploinsufficiency of the hematopoietic transcription factor CBFA2 caused the disease (Song et al. 1999).”
BackgroundHuman blood genomics: distinct profiles for gender, age and neurofibromatosis type 1
Tang, Y., Lu, A., Ran, R., Aronow, B. J., Schorry, E. K., Hopkin, R. J., Gilbert, D. L., Glauser, T. A., Hershey, A. D., Richtand, N. W., et al. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.10.014 · Cited by 45
AML1 Interconnected Pathways of Leukemogenesis: MOLECULAR BIOLOGY AND GENETICS
Michaud, J., Scott, H. S., & Escher, R. (2003) · Cancer Investigation · doi:10.1081/cnv-120018821 · Cited by 53
“Germ-line monoallelic AML1 mutations have now been identified in 10 FPD/AML pedigrees.([76,164,165]) As seen for the sporadic AML1 mutations, all except one mutation fall in the runt domain.”
BackgroundAchievements in Understanding and Treatment of Myelodysplastic Syndromes
Hellström‐Lindberg, E., Willman, C., Barrett, A. J., & Saunthararajah, Y. (2000) · Hematology · doi:10.1182/asheducation.v2000.1.110.110 · Cited by 50
Self-citationPhysical and functional link of the leukemia-associated factors AML1 and PML
Nguyen, L. A., Pandolfi, P. P., Aikawa, Y., Tagata, Y., Ohki, M., & Kitabayashi, I. (2004) · Blood · doi:10.1182/blood-2004-03-1185 · Cited by 46
Gatekeeper function of the RUNX1 transcription factor in acute leukemia
Niebuhr, B., Fischer, M., Täger, M., Cammenga, J., & Stocking, C. (2007) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.07.018 · Cited by 48
Cross Talk between Retinoic Acid Signaling and Transcription Factor GATA-2
Tsuzuki, S., Kitajima, K., Nakano, T., Glasow, A., Zelent, A., & Enver, T. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6824-6836.2004 · Cited by 51
“Haploinsufficiency of transcription factors such as AML-1 provides support for this notion (50, 51), and data from our own laboratory suggest that this may extend to GATA-2 (46; S.”
BackgroundDefinitive hematopoiesis requires Runx1 C-terminal-mediated subnuclear targeting and transactivation
Dowdy, C. R., Xie, R., Frederick, D., Hussain, S., Zaidi, S. K., Vradii, D., Javed, A., Li, X., Jones, S. N., Lian, J. B., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp568 · Cited by 49
Nguyen, T. T., Ma, L., Slovak, M. L., Bangs, C. D., Cherry, A. M., & Arber, D. A. (2006) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20355 · Cited by 53
“…leukemia (ALL), blast crisis of chronic myelogenous leukemia (CML), myelodysplastic syndrome (MDS), and T-cell lymphomas (Kempski et al., 1999; Song et al., 1999; Mikhail et al., 2002; Robinson et al., 2003; Ferro et al., 2004; Ito, 2004; Zelent et al., 2004; Andersen et al., 2005; Steensma…”
BackgroundRunx1 deficiency predisposes mice to T-lymphoblastic lymphoma
Kundu, M., Compton, S. T., Garrett-Beal, L. J., Stacy, T., Starost, M. F., Eckhaus, M., Speck, N. A., & Liu, P. P. (2005) · Blood · doi:10.1182/blood-2005-04-1447 · Cited by 48
Self-citationLiu, T. X., Zhou, Y., Kanki, J. P., Deng, M., Rhodes, J., Yang, H. W., Sheng, X., Zon, L. I., & Look, A. T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072560099 · Cited by 47
Submicroscopic deletions in 5q- associated malignancies.
Crescenzi, B., Starza, R. L., Romoli, S., Beacci, D., Matteucci, C., Barba, G., Aventin, A. M., Marynen, P., Ciolli, S., Nozzoli, C., et al. (2004) · PubMed · Cited by 48
Transcription factor defects causing platelet disorders
Daly, M. E. (2016) · Blood Reviews · doi:10.1016/j.blre.2016.07.002 · Cited by 51
“Arg174Gln) were identified in the remaining two families [34].”
BackgroundRogers, H. J., Nakashima, M. O., & Kottke‐Marchant, K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-47913-4.00002-1 · Cited by 54
Fusion genes in leukemia: an emerging network
Bohlander, S. K. (2000) · Cytogenetic and Genome Research · doi:10.1159/000056818 · Cited by 54
“It has been shown for several of these genes and can be assumed for the others that they play central roles in normal hematopoietic differentiation and lineage commitment (Okuda et al., 1996; Song et al., 1999; Wang et al., 1997; Wang et al., 1998).”
BackgroundRUNX1 translocations in malignant hemopathies.
Braekeleer, E. D., Férec, C., & Braekeleer, M. D. (2009) · PubMed · Cited by 53
Role of RUNX Family Transcription Factors in DNA Damage Response.
Samarakkody, A. S., Shin, N.-Y., & Cantor, A. B. (2020) · PubMed Central · doi:10.14348/molcells.2019.0304 · Cited by 50
“Inherited monoallelic germline RUNX1 mutations cause familial platelet disorder with predisposition to leukemia (FPD/ AML) (Godley, 2014; Jongmans et al., 2010; Osato, 2004; Owen et al., 2008; Song et al., 1999).”
BackgroundInfluentialMorrow, M., Samanta, A., Kioussis, D., Brady, H. J. M., & Williams, O. (2007) · Oncogene · doi:10.1038/sj.onc.1210227 · Cited by 44
“R201Q is the most frequent mutation in the RHD of AML1 in human patients, found in familial platelet disorder with predisposition to AML (Song et al., 1999), AML (Preudhomme et al., 2000) and cleidocranial dysplasia (Quack et al., 1999; Zhou et al., 1999; Otto et al., 2002; Yoshida et al., 2002).”
BackgroundBiology and therapy of secondary leukaemias
Dann, E. J., & Rowe, J. M. (2001) · Best Practice & Research Clinical Haematology · doi:10.1053/beha.2000.0119 · Cited by 42
Lessons in platelet production from inherited thrombocytopenias
Pecci, A., & Balduini, C. L. (2014) · British Journal of Haematology · doi:10.1111/bjh.12752 · Cited by 41
Introduction to cancer genetic susceptibility syndromes
McGee, R. B., & Nichols, K. E. (2016) · Hematology · doi:10.1182/asheducation-2016.1.293 · Cited by 40
Recognition of familial myeloid neoplasia in adults
Brown, A. L., Churpek, J. E., Malcovati, L., Döhner, H., & Godley, L. A. (2017) · Seminars in Hematology · doi:10.1053/j.seminhematol.2016.11.003 · Cited by 41
Jekarl, D. W., Kim, M., Lim, J., Kim, Y., Han, K., Lee, A.-W., Kim, H., & Min, W.-S. (2010) · International Journal of Hematology · doi:10.1007/s12185-010-0650-5 · Cited by 41
“Point mutations in a RUNX1 allele are associated with familial platelet disorder showing a propensity for AML [21].”
BackgroundIncreased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice
Yanagida, M., Osato, M., Yamashita, N., Liqun, H., Jacob, B., Wu, F., Cao, X., Nakamura, T., Yokomizo, T., Takahashi, S., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208675 · Cited by 44
“Haploinsufficiency of RUNX1 causes familial platelet disorder that is associated with a predisposition to developing acute myeloid leukemia (FPD/AML, OMIM 601399) (Song et al., 1999).”
BackgroundBalduini, A., Raslová, H., Buduo, C. A. D., Donada, A., Ballmaier, M., Germeshausen, M., & Balduini, C. L. (2018) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2018.01.014 · Cited by 41
Molecular Control of Megakaryopoiesis and Thrombopoiesis
Matsumura, I., & Kanakura, Y. (2002) · International Journal of Hematology · doi:10.1007/bf02982109 · Cited by 46
“Among these molecules, the AML1 gene was found to be mutated in a familial platelet disorder with predisposition to acute myelogenous leukemia (FPD/AML) [93].”
BackgroundThe t(3;21) fusion product, AML1/Evi-1 blocks AML1-induced transactivation by recruiting CtBP
Izutsu, K., Kurokawa, M., Imai, Y., Ichikawa, M., Asai, T., Maki, K., Mitani, K., & Hirai, H. (2002) · Oncogene · doi:10.1038/sj.onc.1205356 · Cited by 44
“Germ line mutations in the AML1 gene are reported in the pedigrees of familial platelet disorder with predisposition to acute myelogenous leukemia (FPD/AML) (Song et al., 1999).”
BackgroundTumor development: Haploinsufficiency and local network assembly
Smilenov, L. B. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.08.015 · Cited by 47
Nagata, T., & Werner, M. H. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4596 · Cited by 47
Hereditary Predisposition to Hematopoietic Neoplasms
Mangaonkar, A. A., & Patnaik, M. M. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.12.013 · Cited by 46
Screening and diagnosis of inherited platelet disorders
Bourguignon, A., Tasneem, S., & Hayward, C. P. M. (2022) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2022.2049199 · Cited by 45
Lasa, A., Carnicer, M. J., Aventin, A. M., Estivill, C., Brunet, S., Sierra, J., & Nomdedeu, J. F. (2004) · Leukemia · doi:10.1038/sj.leu.2403377 · Cited by 40
Progression of myelodysplastic syndrome: allelic loss on chromosomal arm 1p
Mori, N., Roberta Morosetti, A., Mizoguchi, H., & Koeffler, H. P. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04434.x · Cited by 40
“This has been shown in familial thrombocytopenia disorder with loss of one AML1 allele associated with an increased proclivity to develop AML (Song et al, 1999).”
BackgroundRelapse of TEL-AML1–Positive Acute Lymphoblastic Leukemia in Childhood: A Matched-Pair Analysis
Seeger, K., von Stackelberg, A., Taube, T., Buchwald, D., Körner, G., Suttorp, M., Dörffel, W., Tausch, W., & Henze, G. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.13.3188 · Cited by 49
Goldfarb, A. N. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22142 · Cited by 47
“Marrows of patients with FPD/AML show increased numbers of small hypolobulated megakaryocytes [Heller et al., 2005] and impaired megakaryocytic colony formation [Song et al., 1999].”
BackgroundBorst, S., Sim, X., Poncz, M., French, D. L., & Gadue, P. J. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309197 · Cited by 39
“Familial platelet disorder with a predisposition to acute myeloid leukemia is a rare genetic disorder resulting from heterozygous mutations in the transcription factor RUNX1.”
BackgroundMethodInfluentialSelf-citationGerritsen, M., Yi, G., Tijchon, E. J. H., Kuster, J., Schuringa, J. J., Martens, J. H. A., & Vellenga, E. (2019) · Blood Advances · doi:10.1182/bloodadvances.2018024422 · Cited by 41
“Familial RUNX1 mutations are associated with familial thrombocytopenia, and patients have a predisposition to AML development.(7,8) In addition to the point mutations in the RUNX1 gene, a number of fusion partners of RUNX1 and their deregulating functions have been described in detail, including AML1-ETO,(9) whereas m…”
BackgroundMyeloid translocation gene 16 is required for maintenance of haematopoietic stem cell quiescence
Fischer, M. A., Moreno–Miralles, I., Hunt, A. A., Chyla, B., & Hiebert, S. W. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.500 · Cited by 43
“For RUNX1 and its closely related family member RUNX3, mouse models with deletions of these genes have supported this hypothesis (Song et al , 1999; Li et al , 2002; Silva et al , 2003).”
Peterson, L. F., Wang, Y., Lo, M.-C., Yan, M., Kanbe, E., & Zhang, D.-E. (2007) · Leukemia · doi:10.1038/sj.leu.2404849 · Cited by 39
Muratoglu, S. C., Hough, B., Mon, S. T., & Fossett, N. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2007.08.015 · Cited by 42
“…of vertebrate hematopoiesis because GATA, FOG and RUNX factors are co-expressed and required for megakaryopoiesis (Tsang et al., 1997, 1998; Song et al., 1999; Gaines et al., 2000; Nichols et al., 2000; Freson et al., 2001; Mehaffey et al., 2001; Cantor et al., 2002; Chang et al., 2002;…”
BackgroundMontpetit, A., Larose, J., Boily, G., Langlois, S., Trudel, N., & Sinnett, D. (2004) · Leukemia · doi:10.1038/sj.leu.2403441 · Cited by 46
Linet, M. S., Devesa, S. S., & Morgan, G. J. (2006) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195149616.003.0044 · Cited by 50
Energetic Contribution of Residues in the Runx1 Runt Domain to DNA Binding
Li, Z., Yan, J., Matheny, C., Corpora, T., Bravo, J., Warren, A. J., Bushweller, J. H., & Speck, N. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303973200 · Cited by 41
Self-citationThe E2A-HLF Oncoprotein ActivatesGroucho-Related Genes and SuppressesRunx1
Dang, J., Inukai, T., Kurosawa, H., Goi, K., Inaba, T., Lenny, N. T., Downing, J. R., Stifani, S., & Look, A. T. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.5935-5945.2001 · Cited by 43
“Although the relevance of Grg proteins to leukemogenesis has not been conclusively established, RUNX1 is the gene most commonly disrupted by chromosomal abnormalities (8) and inactivated by point mutation in human leukemia (49).”
BackgroundHaploinsufficiency of Runx1/AML1 promotes myeloid features and leukaemogenesis in BXH2 mice
Yamashita, N., Osato, M., Huang, L., Yanagida, M., Kogan, S. C., 岩崎, 正., Nakamura, T., Shigesada, K., Asou, N., & Ito, Y. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05793.x · Cited by 41
Li, F., Person, R., Takemaru, K., Williams, K., Meade-White, K. D., Ozsahin, A. H., Güngör, T., Moon, R. T., & Horwitz, M. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310759200 · Cited by 44
Self-citationClinical significance of Gata‐1, Gata‐2, EKLF, and c‐MPL expression in acute myeloid leukemia
Ayala, R. M., Martínez‐López, J., Albízua, E., Díez, A., & Gilsanz, F. (2008) · American Journal of Hematology · doi:10.1002/ajh.21332 · Cited by 43
Horwitz, M. S., Benson, K. F., Duan, Z., Person, R., Wechsler, J., Williams, K., Albani, D., & Li, F. (2003) · Current Opinion in Hematology · doi:10.1097/00062752-200301000-00008 · Cited by 38
Self-citationThe role of AGK in thrombocytopoiesis and possible therapeutic strategies
Jiang, H., Yu, Z., Ding, N., Yang, M., Zhang, L., Fan, X., Zhou, Y., Zou, Q., Hou, J. Q., Zheng, J., et al. (2020) · Blood · doi:10.1182/blood.2019003851 · Cited by 37
van der Crabben, S. N., van Binsbergen, E., Ausems, M. G. E. M., Poot, M., Bierings, M., & Buijs, A. (2009) · Leukemia Research · doi:10.1016/j.leukres.2009.06.030 · Cited by 38
Fukushima‐Nakase, Y., Naoe, Y., Taniuchi, I., Hosoi, H., Sugimoto, T., & Okuda, T. (2005) · Blood · doi:10.1182/blood-2004-08-3372 · Cited by 38
A novel RUNX1 mutation in familial platelet disorder with propensity to develop myeloid malignancies
Kirito, K., Sakoe, K., Shinoda, D., Takiyama, Y., Kaushansky, K., & Komatsu, N. (2007) · Haematologica · doi:10.3324/haematol.12050 · Cited by 43
“Genetic and molecular studies reveal that all reported pedigrees of FPD/MM display a mutation in the RUNX1 gene or LOH at the locus.(5-10) In this report, we present a Japanese family with FPD/MM and a novel RUNX1 mutation.”
BackgroundZang, C., Luyten, A., Chen, J., Liu, X. S., & Shivdasani, R. A. (2016) · Scientific Reports · doi:10.1038/srep30255 · Cited by 39
Kratz, C. P., Emerling, B. M., Bonifas, J. M., Wang, W. C., Green, E. D., Beau, M. M. L., & Shannon, K. (2002) · Blood · doi:10.1182/blood.v99.1.372 · Cited by 37
RUNX genes, neoplasia, and cleidocranial dysplasia
Cohen, M. M. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.10064 · Cited by 40
Leukaemia – a developmental perspective
Izraeli, S. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04986.x · Cited by 42
“…mutations cause the autosomal-dominant familial platelet disorder with a propensity to develop acute myeloid leukaemia (AML) [FDP/AML syndrome, Online Mendelian Inheritance in Man (OMIM) number no. 601399 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db¼OMIM] (Song et al, 1999; Sun et al, 2004).”
BackgroundMicrodeletion of the Down syndrome critical region at 21q22
Fujita, H., Torii, C., Kosaki, R., Yamaguchi, S., Kudoh, J., Hayashi, K., Takahashi, T., & Kosaki, K. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33228 · Cited by 36
“Among the 20 deleted genes in the presently reported patient, only one gene, RUNX1, has been unequivocally associated with autosomal dominant traits in humans: monoallelic RUNX1 germline mutations have been found in autosomal dominant familial platelet disorder with a predisposition to acute myelogeneous leukemia (FPD…”
BackgroundBotero, J. P., Oliveira, J. L., Chen, D., Reichard, K. K., Viswanatha, D. S., Nguyen, P. L., Pruthi, R. K., Majerus, J. A., Gada, P., Gangat, N., et al. (2015) · Blood Cancer Journal · doi:10.1038/bcj.2015.41 · Cited by 36
Haploinsufficiency for Tumor Suppression
Largaespada, D. A. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.4.f15 · Cited by 36
“In people, inheritance of one mutant copy of the AML1 gene causes a thrombocytopenia with predisposition to acute myeloid leukemia (AML) development (3).”
Understanding the Continuum between High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia
Zavras, P. D., Sinanidis, I., Tsakiroglou, P., & Karantanos, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24055018 · Cited by 37
“Germline point mutations of RUNX1 have been identified in an autosomal dominant platelet disorder with a high risk of transformation to AML [75].”
BackgroundTranscriptional Auto-Regulation of RUNX1 P1 Promoter
Martínez, M., Hinojosa, M., Trombly, D. J., Morín, V., Stein, J. L., Stein, G. S., Javed, A., & Gutierrez, S. E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149119 · Cited by 39
Xu, X., Bryke, C. R., SUKHANOVA, M. J., Huxley, E., Dash, D. P., Dixon‐McIver, A., Fang, M., Griepp, P., Hodge, J. C., Iqbal, M. A., et al. (2018) · Cancer Genetics · doi:10.1016/j.cancergen.2018.07.005 · Cited by 36
Control of Self‐Renewal and Differentiation of Hematopoietic Stem Cells: HOXB4 on the Threshold
Klump, H., Schiedlmeier, B., & Baum, C. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1349.002 · Cited by 45
Thrombocytopenias: a clinical point of view.
Veneri, D., Franchini, M., Randon, F., Nichele, I., Pizzolo, G., & Ambrosetti, A. (2009) · PubMed · doi:10.2450/2008.0012-08 · Cited by 47
Current Knowledge on the Pathophysiology of Fanconi Anemia: From Genes to Phenotypes
Yamashita, T., & Nakahata, T. (2001) · International Journal of Hematology · doi:10.1007/bf02982547 · Cited by 37
“A number of acquired and inherited bone marrow failure syndromes, to varying degrees, predispose patients to clonal hematopoietic disorders [111-113].”
Background
Metadata
- Authors
- Song, W.-J., Sullivan, M. G., Legare, R. D., Hutchings, S., Tan, X., Kufrin, D., Ratajczak, J., Resende, I. C., Haworth, C., Hock, R., Loh, M., Felix, C., Roy, D.-C., Busque, L., Kurnit, D., Willman, C., Gewirtz, A. M., Speck, N. A., Bushweller, J. H., Li, F. P., Gardiner, K., Poncz, M., Maris, J. M., & Gilliland, D. G.
- Affiliations
- Brigham and Women's Hospital (US)
- Brown University (US)
- University of Pennsylvania (US)
- Leicester Royal Infirmary (GB)
- St Vincent Hospital (US)
- Hôpital Maisonneuve-Rosemont (CA)
- University of Michigan (US)
- University of New Mexico (US)
- Dartmouth College (US)
- University of Virginia (US)
- Harvard University (US)
- Roosevelt Institute (US)
- Corresponding author
- Gilliland, D. Gary
- ORCID
- Venue
- Nature Genetics
- Published
- 1999-10
- Volume
- 23
- Issue
- 2
- Pages
- 166-175
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1739103212
- Cited by
- 1,100
- References
- 49
- Citations by year
- 2026: 9 · 2025: 23 · 2024: 27 · 2023: 32 · 2022: 29 · 2021: 36 · 2020: 46 · 2019: 33 · 2018: 26 · 2017: 61 · 2016: 54 · 2015: 35 · 2014: 30 · 2013: 33 · 2012: 53
- FWCI
- 25.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (7r29ai039536-04)
- National Cancer Institute (R01CA081932, R01-CA78545, R01 CA81932, R01CA078545)
- National Institute of Allergy and Infectious Diseases (R29 AI39536)
- Topics
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Keywords
- RUNX1, haploinsufficiency, autosomal dominant inheritance, missense mutations, megakaryopoiesis, megakaryocyte colony formation, platelet disorders, chromosome 21q, nonsense mutation, intragenic deletion
- MeSH terms
- Amino Acid Sequence, Base Sequence, Blood Platelets, Chromosome Mapping, Colony-Forming Units Assay, DNA Mutational Analysis, DNA-Binding Proteins, Family Health, Female, Genotype, Hematopoiesis, Heterozygote, Humans, Male, Megakaryocytes, Molecular Sequence Data, Mutation, Pedigree, Proto-Oncogene Proteins, RNA, Sequence Homology, Nucleic Acid, Thrombocytopenia, Transcription Factors, Leukemia, Myeloid, Acute, Sequence Deletion, Sequence Homology, Amino Acid, In Situ Hybridization, Fluorescence, Microsatellite Repeats, Genetic Predisposition to Disease, Reverse Transcriptase Polymerase Chain Reaction, Core Binding Factor Alpha 2 Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.